• Human iPSC-Derived Sensory Neurons Model HSV-1 Latency In Vi

  2026-05-25

  This study establishes a robust, scalable protocol to differentiate human inducible pluripotent stem cells (hiPSCs) into functional sensory neurons for modeling latent herpes simplex virus 1 (HSV-1) infection and reactivation. The model recapitulates key molecular hallmarks of HSV-1 latency in human neurons and provides a new platform for mechanistic and therapeutic research.

• Comparative In Vitro Activity of Sisomicin and Tobramycin

  2026-05-24

  This article examines the pivotal reference study comparing the in vitro antibacterial activity of sisomicin to established aminoglycosides, including tobramycin and gentamicin, across a broad panel of clinical isolates. The findings illuminate nuanced differences in efficacy among key agents for Gram-negative and Gram-positive pathogens, with direct implications for antibiotic resistance research and microbiology assay design.

• Meropenem: β-Lactam Antibiotic Carbapenem in Resistance Mode

  2026-05-23

  Unlock the full experimental power of Meropenem, an ultra-broad-spectrum β-lactam antibiotic carbapenem, for dissecting Gram-negative and Gram-positive resistance mechanisms. This guide delivers actionable workflows, troubleshooting strategies, and cutting-edge insights grounded in both foundational and reference research.

• Biotin-tyramide: Technical Guide for Enzyme-Mediated TSA

  2026-05-22

  Biotin-tyramide (SKU A8011) is used to amplify detection sensitivity in immunohistochemistry (IHC) and in situ hybridization (ISH) workflows, solving the challenge of visualizing low-abundance targets. It is not intended for diagnostic or clinical applications and should be avoided outside validated, enzyme-mediated amplification protocols.

• JC-1 in Mitochondrial Membrane Potential Assays: Applied Ins

  2026-05-22

  JC-1 (5,6-dichloro-2-[(E)-3-(5,6-dichloro-1,3-diethylbenzimidazol-3-ium-2-yl)prop-2-enylidene]-1,3-diethylbenzimidazole iodide) empowers researchers to quantify mitochondrial membrane potential changes with high sensitivity and workflow reproducibility. Integrating recent mechanistic findings, this guide details optimized protocols, advanced use-cases, and troubleshooting strategies that leverage APExBIO’s high-purity JC-1 for robust apoptosis detection and mitochondrial dysfunction research.

• Dual-Action Kinase Inhibitors Enhance p38α Dephosphorylation

  2026-05-21

  The reference study reveals that some p38α MAP kinase inhibitors not only block kinase activity but also actively promote dephosphorylation of the activation loop, offering a dual-action mechanism. These findings provide new structural and mechanistic insight into kinase-phosphatase interplay and suggest novel strategies for improving the specificity and efficacy of kinase-targeted therapies in inflammatory disease research.

• DiR (DiIC 18 (7)): Mechanistic Insights for Precision Membra

  2026-05-21

  Explore how DiR (DiIC 18 (7)) unlocks precise, long-term membrane labeling and cell tracking. This article uncovers mechanistic principles and advanced assay design strategies, offering unique guidance beyond standard protocols.

• Sulfamonomethoxine: Precision Antibiotic Stewardship in Vete

  2026-05-20

  Explore Sulfamonomethoxine (SMM) as a precision veterinary antibiotic, emphasizing advanced stewardship strategies, nuanced environmental impact, and practical assay guidance. This article offers a unique, evidence-driven perspective that extends beyond mechanistic overviews to actionable best practices.

• Alda 1: ALDH2 Activator for Cardiac Ischemia and Dermatitis

  2026-05-20

  Alda 1, a potent ALDH2 activator from APExBIO, stands out for its ability to enhance both wild-type and mutant ALDH2 function, enabling advanced cardiac ischemia research and radiation-induced dermatitis mitigation. Recent breakthroughs reveal its unique role in extending cardiomyocyte proliferation, unlocking new experimental workflows for cardiac regeneration.

• RG108: Precision DNA Methyltransferase Inhibition for Transl

  2026-05-19

  This article explores the mechanistic foundation and strategic application of RG108, a small-molecule DNA methyltransferase inhibitor, for translational researchers seeking to modulate epigenetic landscapes in cancer and stem cell models. By integrating recent findings and best-practice protocols, we address how RG108 enables robust demethylation, tumor suppressor gene reactivation, and workflow optimization—guiding researchers from experimental design through to translational relevance.

• α-Amanitin (SKU A4548): Reliable RNA Polymerase II Inhibitio

  2026-05-19

  Discover how α-Amanitin (SKU A4548) from APExBIO provides precision RNA polymerase II inhibition for challenging laboratory workflows in gene expression and preimplantation embryo development studies. This scenario-driven article offers practical guidance and validated protocols for biomedical researchers seeking dependable, reproducible transcriptional regulation tools.

• Cefiderocol Efficacy vs. Resistant P. aeruginosa & Acinetoba

  2026-05-18

  This study presents a large-scale, direct comparison of cefiderocol and β-lactam/β-lactamase inhibitor combinations against European Pseudomonas aeruginosa and Acinetobacter spp., including multidrug-resistant isolates. Its findings define the high in vitro activity of cefiderocol, even in strains resistant to meropenem and modern β-lactam/β-lactamase inhibitors, with implications for resistance surveillance and antibiotic selection.

• Modular Inflammation Networks in Mutagenized Mouse Brains

  2026-05-18

  Xiong et al. present a scalable RNA-seq framework to map discrete inflammatory gene modules in genetically heterogeneous mouse brains. By interrogating ENU-induced variants linked to CNS disorders, the study delineates modular neuroimmune states, offering a foundation for targeted modulation strategies in neuroinflammation research.

• Angiotensin 1/2 (1-6): Precision in Cardiovascular & Viral A

  2026-05-17

  Angiotensin 1/2 (1-6) empowers researchers with a high-purity, mechanistically validated tool for dissecting renin-angiotensin system functions across cardiovascular, renal, and viral pathogenesis domains. This article presents actionable workflows, evidence-driven troubleshooting, and highlights breakthrough cross-domain insights enabled by APExBIO’s rigorously characterized hexapeptide.

• Hypoxia-Induced Cognitive Impairment via Choroid Plexus Disr

  2026-05-16

  This study elucidates how simulated high-altitude hypoxia impairs cognitive function in mice by disrupting the choroid plexus barrier and promoting M1 macrophage polarization, with aberrant AMPK signaling as a key mechanistic driver. The findings provide a detailed pathway underlying hypoxia-induced CNS dysfunction, highlighting the choroid plexus as a therapeutic target.

436 records 16/30 page Previous Next First page 上5页 1617181920 下5页 Last page